Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Resvita Bio develops and manufactures engineered probiotics for use in treatment if skin related diseases including cancer.
Lasarrus develops devices for patients with chronic obstructive pulmonary disease.
Medical Device Research and Development
EndoTheia is a medical equipment manufacturing firm that supplies the next generation of flexible endoscopic devices.
Xylyx Bio creates effective science-based solutions for the benefit of human life and health.
ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.
Evoq Therapeutics is a cancer immunotherapy company that provides disease-specific immune modulators.
Reduce clinical variation and gain 10x efficiencies – continuous insights and monitoring
This company is a Boston-based biopharmaceutical company developing immune-based approaches.
Penderia Technologies is a new medical device company that specializes in creative ways to treat orthopedic ailments.
Kinoxis Therapeutics is a biotechnology company that develops a range of novel therapeutic compounds.
Aldatu Biosciences is the leader in adaptive PCR diagnostics for global health and emerging diseases.
MaMome uses microbiome analysis and ML to improve maternal health by detecting high-risk pregnancies early.
Orlance provides more effective therapeutic and preventive vaccines for a wide spectrum of viral targets.
CUNY SPH delivers online graduate education that prepares students for success in all domains of public health.
Neuroene Therapeutics offers novel small molecule mitochondrial therapeutics for epilepsy, Parkinson's Disease, and mitochondrial disease.
Matter Bio operates as company focus on preserving genome integrity.
Hesperos, Inc, is a leader in efforts to characterize an individual’s biology with human-on-a-chip microfluidic systems.
Annoviant is a healthcare company that develops medical devices.
Selsym Biotech is a biotechnology developer whose goal is to provide innovative platelet-mimetic therapies for the treatment.
Magnasense will create technology for biomarker assays that are easily accessible.
Enable Biosciences is a biotech company.
SeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.
AivoCode is an emerging biotech focused on critical and highly prevalent diseases affecting the central nervous system
National Institutes of Health has invested in 491 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Medical Device. The firm invests across 16 different industry categories.
Among tracked funding rounds, ONL Therapeutics received $65.0M in a Series D round. National Institutes of Health's total known invested capital is $2.5B.
National Institutes of Health's average investment size is $5.9M across its portfolio of 491 companies.
Recent National Institutes of Health portfolio additions include Resvita Bio, Lasarrus, Cx Therapeutics, EndoTheia, Xylyx Bio. These companies were founded in 2020 or later.